Persistent phenothiazine dyskinesia treated with tetrabenazine.
作者信息
Godwin-Austen R B, Clark T
出版信息
Br Med J. 1971 Oct 2;4(5778):25-6. doi: 10.1136/bmj.4.5778.25.
Abstract
Six patients with persistent phenothiazine dyskinesia were treated in a double-blind controlled trial with tetrabenazine 100 mg in divided dosage. In three patients the abnormal movements were abolished and in two others there was some improvement, but this was no greater than that achieved with the diazepam control. Tetrabenazine may be useful in the treatment of some patients with persistent phenothiazine dyskinesia.
摘要
相似文献
1
Persistent phenothiazine dyskinesia treated with tetrabenazine.
Br Med J. 1971 Oct 2;4(5778):25-6. doi: 10.1136/bmj.4.5778.25.
2
Tardive dyskinesia.
Am Fam Physician. 1974 May;9(5):101-5.
3
Treatment of phenothiazine induced bulbar persistent dyskinesia with deanol acetamidobenzoate.用乙酰氨基苯甲酸二乙胺治疗吩噻嗪引起的延髓持续性运动障碍。
Dis Nerv Syst. 1975 Feb;36(2):71-3.
4
Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
Clin Pediatr (Phila). 1975 Oct;14(10):953-5. doi: 10.1177/000992287501401013.
5
Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy.
J Nerv Ment Dis. 1966 Jul;143(1):73-9. doi: 10.1097/00005053-196607000-00008.
6
Tetrabenazine and movement disorders.
Neurology. 1981 Aug;31(8):1051-4. doi: 10.1212/wnl.31.8.1051.
7
Phenothiazine-induced dyskinesia in nursing-home patients.养老院患者中吩噻嗪引起的运动障碍。
J Am Geriatr Soc. 1968 Jan;16(1):27-34. doi: 10.1111/j.1532-5415.1968.tb03966.x.
8
Treatment of persistent phenothiazine-induced oral dyskinesia.
Br J Psychiatry. 1970 Mar;116(532):277-80. doi: 10.1192/bjp.116.532.277.
9
Deanol in the treatment of tardive dyskinesia.二甲氨基乙醇治疗迟发性运动障碍
Am J Psychiatry. 1975 Aug;132(8):864-7. doi: 10.1176/ajp.132.8.864.
10
Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
Med J Aust. 1972 Aug 5;2(6):314-6. doi: 10.5694/j.1326-5377.1972.tb47308.x.
引用本文的文献
1
Clinical practice guidelines for the treatment of tardive dyskinesia in Europe: A descriptive review.欧洲迟发性运动障碍治疗临床实践指南：描述性综述
Eur Psychiatry. 2025 Jul 17;68(1):e115. doi: 10.1192/j.eurpsy.2025.10047.
2
VMAT2 Inhibitors in Neuropsychiatric Disorders.VMAT2 抑制剂在神经精神疾病中的应用。
CNS Drugs. 2018 Dec;32(12):1131-1144. doi: 10.1007/s40263-018-0580-y.
3
Benzodiazepines for antipsychotic-induced tardive dyskinesia.用于抗精神病药物所致迟发性运动障碍的苯二氮䓬类药物。
Cochrane Database Syst Rev. 2018 Jan 20;1(1):CD000205. doi: 10.1002/14651858.CD000205.pub3.
4
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.用于抗精神病药物所致迟发性运动障碍的非抗精神病类儿茶酚胺能药物。
Cochrane Database Syst Rev. 2018 Jan 18;1(1):CD000458. doi: 10.1002/14651858.CD000458.pub3.
5
Tetrabenazine: Spotlight on Drug Review.丁苯那嗪：药物审评聚焦
Ann Neurosci. 2016 Sep;23(3):176-185. doi: 10.1159/000449184. Epub 2016 Sep 9.
6
Chlorpromazine versus placebo for schizophrenia.氯丙嗪与安慰剂治疗精神分裂症的对比
Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3.
7
Benzodiazepines in psychotic States.苯二氮䓬类药物在精神病态中的应用。
Indian J Psychiatry. 1993 Apr;35(2):73-80.
8
Tardive Dyskinesia.迟发性运动障碍
Curr Treat Options Neurol. 2000 May;2(3):205-214. doi: 10.1007/s11940-000-0003-4.
9
Management of tardive dyskinesia: current update.迟发性运动障碍的管理：当前进展
Drugs. 1982 May;23(5):381-93. doi: 10.2165/00003495-198223050-00003.
10
Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.丁苯那嗪（Nitoman）治疗慢性自发性口腔运动障碍。一项视频和肌电图控制的研究。
Eur Arch Psychiatry Neurol Sci. 1984;234(3):172-4. doi: 10.1007/BF00461557.
本文引用的文献
1
[Neurological complications of neuroleptic medication].[抗精神病药物的神经并发症]
Rev Neurol (Paris). 1959 Jun;100:553-95.
2
AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.一种在服用吩噻嗪类药物后出现的明显不可逆的异常运动综合征。
Proc R Soc Med. 1964 Aug;57(8):758-62. doi: 10.1177/003591576405700835.
3
Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.
Acta Psychiatr Scand. 1970;46(4):323-6. doi: 10.1111/j.1600-0447.1970.tb02123.x.
Zotero 插件